AlphaStocks
1.3
Avoid

Hims & Hers Health, Inc. (HIMS)

Health Care / Health Care Services

S&P MidCap 400

$19.84

Scores poorly across most models. Proceed with caution.

Avoid

Score based on 4 of 5 models — moderate confidence

#1114out of 1127 in Health Care

Is Hims & Hers Health, Inc. a Good Investment in 2026?

Hims & Hers Health, Inc. (HIMS) scores 1.3 out of 10 on AlphaStocks' composite model, earning a Avoid rating. The Piotroski model is the most favorable, rating Hims & Hers Health, Inc. as Neutral. However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 78%). Hims & Hers Health, Inc. currently trades above its estimated fair value of $12, suggesting limited upside at current prices. Hims & Hers Health, Inc. ranks #1114 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E39.9ROE18.8Market Cap5B

Estimated Fair Value

$12.1264% above

Trading above estimated fair value. P/e of 40x implies high growth expectations. eps growth of -7% may not justify the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

4/9

Buffett

Caution

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Limited Data

Growth rate vs price (PEG)

Greenblatt

Caution

Bottom half (rank 78%)

Frequently Asked Questions

Is Hims & Hers Health, Inc. (HIMS) a good investment?
Based on AlphaStocks' composite analysis, Hims & Hers Health, Inc. (HIMS) scores 1.3 out of 10, earning a Avoid rating. This score is below average, suggesting caution. Trading above estimated fair value. P/e of 40x implies high growth expectations. eps growth of -7% may not justify the premium.
What is Hims & Hers Health, Inc.'s Piotroski F-Score?
Hims & Hers Health, Inc.'s Piotroski F-Score status is Neutral. The raw score is 4/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is HIMS overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $12, HIMS appears overvalued. The stock currently trades 64% above its estimated fair value. Trading above estimated fair value. P/e of 40x implies high growth expectations. eps growth of -7% may not justify the premium.
How does HIMS compare to other Health Care stocks?
Hims & Hers Health, Inc. ranks #1114 out of 1127 stocks in the Health Care sector, placing it in the top 99% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about HIMS?
AlphaStocks evaluates HIMS using five proven investment models. Piotroski: Neutral; Buffett: Caution; Graham: Caution; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 1.3/10.

Similar Stocks

PARRFTIAZN

Compare HIMS with

HIMS vs PARRHIMS vs FTIHIMS vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer